| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing gene targeting for primary immune deficiencies: Adenine base editing of the human IL2RG locus for correction of SCID-X1
|
McIvor, R. Scott
|
|
|
32 |
6 |
p. 1606-1608
|
artikel
|
| 2 |
A new step toward non-genotoxic conditioning prior to hematopoietic stem cell transplantation
|
Cavazzana, Marina
|
|
|
32 |
6 |
p. 1604-1605
|
artikel
|
| 3 |
An innate immune response to adeno-associated virus genomes decreases cortical dendritic complexity and disrupts synaptic transmission
|
Suriano, Christos M.
|
|
|
32 |
6 |
p. 1721-1738
|
artikel
|
| 4 |
Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas
|
Choi, Sung Hugh
|
|
|
32 |
6 |
p. 2030
|
artikel
|
| 5 |
Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant
|
Yeung, Jenny
|
|
|
32 |
6 |
p. 1672-1686
|
artikel
|
| 6 |
Bis-2′-F-cGSASMP isomers encapsulated in cytidinyl/cationic lipids act as potent in situ autologous tumor vaccines
|
Yu, Jing
|
|
|
32 |
6 |
p. 1917-1933
|
artikel
|
| 7 |
Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice
|
Zhou, Jinge
|
|
|
32 |
6 |
p. 1779-1789
|
artikel
|
| 8 |
Controlling CAR-T cell activity and specificity with synthetic SparX adapters
|
Edwards, Justin P.
|
|
|
32 |
6 |
p. 1835-1848
|
artikel
|
| 9 |
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia
|
Nasri, Masoud
|
|
|
32 |
6 |
p. 1628-1642
|
artikel
|
| 10 |
Decoding and overcoming T cell exhaustion: Epigenetic and transcriptional dynamics in CAR-T cells against solid tumors
|
Ahn, Taeyoung
|
|
|
32 |
6 |
p. 1617-1627
|
artikel
|
| 11 |
Defining mesenchymal stem/stromal cell-induced myeloid-derived suppressor cells using single-cell transcriptomics
|
Lee, Hyun Ju
|
|
|
32 |
6 |
p. 1970-1983
|
artikel
|
| 12 |
Empowering virus-free CAR immune cell therapies
|
Bexte, Tobias
|
|
|
32 |
6 |
p. 1609-1611
|
artikel
|
| 13 |
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy
|
Li, Yan-Ruide
|
|
|
32 |
6 |
p. 1849-1874
|
artikel
|
| 14 |
Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease
|
Herstine, Jessica A.
|
|
|
32 |
6 |
p. 1701-1720
|
artikel
|
| 15 |
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies
|
Skeate, Joseph G.
|
|
|
32 |
6 |
p. 1817-1834
|
artikel
|
| 16 |
Fast, accurate ranking of engineered proteins by target-binding propensity using structure modeling
|
Ding, Xiaozhe
|
|
|
32 |
6 |
p. 1687-1700
|
artikel
|
| 17 |
GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness
|
Niu, Qing
|
|
|
32 |
6 |
p. 1875-1894
|
artikel
|
| 18 |
Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression
|
Santhanam, Manikandan
|
|
|
32 |
6 |
p. 1934-1955
|
artikel
|
| 19 |
In this issue
|
|
|
|
32 |
6 |
p. 1598-1599
|
artikel
|
| 20 |
In vitro and in vivo validation of the antiviral effect of hCypA against SARS-CoV-2 via binding to the RBD of spike protein
|
Shin, Woo-Ri
|
|
|
32 |
6 |
p. 1805-1816
|
artikel
|
| 21 |
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
|
Holliday, Holly
|
|
|
32 |
6 |
p. 2031-2033
|
artikel
|
| 22 |
mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
|
Montoya, Brian
|
|
|
32 |
6 |
p. 1790-1804
|
artikel
|
| 23 |
Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study
|
Zhang, Yalei
|
|
|
32 |
6 |
p. 2000-2020
|
artikel
|
| 24 |
Quo vadis American postdoc?
|
Herzog, Roland W.
|
|
|
32 |
6 |
p. 1597
|
artikel
|
| 25 |
Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing
|
Zhang, Lu
|
|
|
32 |
6 |
p. 1658-1671
|
artikel
|
| 26 |
Retraction Notice to: Corrigendum to “Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders”
|
Javed, Hayate
|
|
|
32 |
6 |
p. 2035
|
artikel
|
| 27 |
Retraction Notice to: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders
|
Javed, Hayate
|
|
|
32 |
6 |
p. 2034
|
artikel
|
| 28 |
Retraction Notice to: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
|
Wu, Ye
|
|
|
32 |
6 |
p. 2036
|
artikel
|
| 29 |
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors
|
Ganesh, Shanthi
|
|
|
32 |
6 |
p. 1895-1916
|
artikel
|
| 30 |
Single-cell transcriptomics unveil a unique molecular profile of mesenchymal stem/stromal cell-induced myeloid-derived immune suppressor cells
|
Hammad, Mohamed
|
|
|
32 |
6 |
p. 1612-1613
|
artikel
|
| 31 |
Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma
|
Xia, Fan
|
|
|
32 |
6 |
p. 1760-1778
|
artikel
|
| 32 |
Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transition
|
Lin, Jianxiang
|
|
|
32 |
6 |
p. 1956-1969
|
artikel
|
| 33 |
TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage
|
Seclen, Eduardo
|
|
|
32 |
6 |
p. 1643-1657
|
artikel
|
| 34 |
Targeting astrocytes with in vivo gene addition: Can it rescue loss of brain myelin?
|
Gong, Yi
|
|
|
32 |
6 |
p. 1602-1603
|
artikel
|
| 35 |
Targeting the nuclear long noncoding transcript LSP1P5 abrogates extracellular matrix deposition by trans-upregulating CEBPA in keloids
|
Gu, Shuchen
|
|
|
32 |
6 |
p. 1984-1999
|
artikel
|
| 36 |
The invisible hand: How epigenetics shapes CAR T cell destiny
|
Ali, Alaa
|
|
|
32 |
6 |
p. 1614-1616
|
artikel
|
| 37 |
Toward the full potential of mRNA therapeutics
|
McNamara II, James O.
|
|
|
32 |
6 |
p. 1600-1601
|
artikel
|
| 38 |
Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer
|
Maggadottir, Solrun Melkorka
|
|
|
32 |
6 |
p. 2021-2029
|
artikel
|
| 39 |
Transplantation of dorsal root ganglia overexpressing the NaChBac sodium channel improves locomotion after complete SCI
|
Hingorani, Sonia
|
|
|
32 |
6 |
p. 1739-1759
|
artikel
|
Tijdschrift beschrijving